Tetsuo Nakano

Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk

Toshitaka Nakamura, Toshitsugu Sugimoto, Tetsuo Nakano et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 254 citations · Full text

<i>Clinical Trials Express:</i>Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)

Toshitaka Nakamura, Toshio Matsumoto, Toshitsugu Sugimoto et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 162 citations · Full text

The Risk of a Second Hip Fracture in Patients after Their First Hip Fracture

Hiroshi Hagino, Takeshi Sawaguchi, Naoto Endo et al. · Calcified Tissue International · 2011 · 135 citations

Bone Disease, Skeletal Trauma, Orthopaedics +4

Effects of unipedal standing balance exercise on the prevention of falls and hip fracture among clinically defined high-risk elderly individuals: a randomized controlled trial

Keizo Sakamoto, Toshitaka Nakamura, Hiroshi Hagino et al. · Journal of Orthopaedic Science · 2006 · 87 citations

Balance Exercise, High-risk Elderly Individuals, Orthopaedic Surgery +16

Predictors for Ambulatory Ability and the Change in ADL After Hip Fracture in Patients With Different Levels of Mobility Before Injury

Naoshi Fukui, Yoshinobu Watanabe, Tetsuo Nakano et al. · Journal of Orthopaedic Trauma · 2011 · 85 citations